Objective： To investigate the possible mechanisms in acupuncture analgesia by interaction of δ-opioid receptor with neurotransmitter transport proteins or the Na^＋-K^＋ pump. Methods： Microinjection of respective ...Objective： To investigate the possible mechanisms in acupuncture analgesia by interaction of δ-opioid receptor with neurotransmitter transport proteins or the Na^＋-K^＋ pump. Methods： Microinjection of respective heterologous cRNA into the Xenopus oocytes as a model system, and measurement of steady-state currents under two-electrode voltage clamp. Results： The co-expression of the 8-opioid receptor with GAT1, EAAC 1 or the sodium pump resulted in reducing activity of the respective transporter. Opioid receptor activation affected transporter activity in different ways： 1） GAT1 was further inhibited; 2） EAAC1 was stimulated; 3） Na^＋-K^＋ pump activity interfered with agonist sensitivity of DOR. Pump inhibition led to higher sensitivity for DPDPE. Conclusion： GABA transporter inhibition and glutamate transporter stimulation may counteract pain sensation by affecting the neurotransmitter concentration in the synaptic cleft and, therefore, may contribute synergistically to pain suppression by acupuncture. Sodium pump inhibition by endogenous ouabain may amplify these effects. These synergistic effects may be the molecular mechanism of inhibiting pain sense and/or acupuncture analgesia.展开更多
目的目前对于特异性调控分泌酶剪切淀粉样蛋白前体蛋白的分子机制尚不十分清楚,而临床上抗阿尔兹海默症(A lzhe im ers′D isease,AD)药物的疗效也不足以从根本上缓解病理症状的恶化。对G-蛋白偶联受体(G-prote in coup led receptors,G...目的目前对于特异性调控分泌酶剪切淀粉样蛋白前体蛋白的分子机制尚不十分清楚,而临床上抗阿尔兹海默症(A lzhe im ers′D isease,AD)药物的疗效也不足以从根本上缓解病理症状的恶化。对G-蛋白偶联受体(G-prote in coup led receptors,GPCR s)在AD疾病进程的调节机制相关研究进展予以总结,对于以GPCR作为药物靶点的潜在可能性进行讨论。方法对于特异性调控分泌酶剪切淀粉样蛋白前体蛋白的分子机制相关的细胞生物学领域以及AD疾病模型上对于发病机制的研究进展进行总结归纳,并针对该领域的几个重要科学问题进行讨论。结果与结论GPCR对于AD疾病进程的调节机制,尤其是其与分泌酶形成的复合体对于β-淀粉样蛋白(amyloid-,βAβ)产生以及AD发病的调节机制,具有理想的特异性,可成为抗AD药物的新型潜在靶点。展开更多
基金the Science Foundation of Shanghai Municipal Commission of Science and Technology(05DZ19745,06DZ19732,064319053,07DZ19722,07DZ19733)the National Basic Research Program of China(973 Program,2005CB523306)Shanghai Leading Academic Discipline Project(B112 and T0302)
文摘Objective： To investigate the possible mechanisms in acupuncture analgesia by interaction of δ-opioid receptor with neurotransmitter transport proteins or the Na^＋-K^＋ pump. Methods： Microinjection of respective heterologous cRNA into the Xenopus oocytes as a model system, and measurement of steady-state currents under two-electrode voltage clamp. Results： The co-expression of the 8-opioid receptor with GAT1, EAAC 1 or the sodium pump resulted in reducing activity of the respective transporter. Opioid receptor activation affected transporter activity in different ways： 1） GAT1 was further inhibited; 2） EAAC1 was stimulated; 3） Na^＋-K^＋ pump activity interfered with agonist sensitivity of DOR. Pump inhibition led to higher sensitivity for DPDPE. Conclusion： GABA transporter inhibition and glutamate transporter stimulation may counteract pain sensation by affecting the neurotransmitter concentration in the synaptic cleft and, therefore, may contribute synergistically to pain suppression by acupuncture. Sodium pump inhibition by endogenous ouabain may amplify these effects. These synergistic effects may be the molecular mechanism of inhibiting pain sense and/or acupuncture analgesia.
文摘目的目前对于特异性调控分泌酶剪切淀粉样蛋白前体蛋白的分子机制尚不十分清楚,而临床上抗阿尔兹海默症(A lzhe im ers′D isease,AD)药物的疗效也不足以从根本上缓解病理症状的恶化。对G-蛋白偶联受体(G-prote in coup led receptors,GPCR s)在AD疾病进程的调节机制相关研究进展予以总结,对于以GPCR作为药物靶点的潜在可能性进行讨论。方法对于特异性调控分泌酶剪切淀粉样蛋白前体蛋白的分子机制相关的细胞生物学领域以及AD疾病模型上对于发病机制的研究进展进行总结归纳,并针对该领域的几个重要科学问题进行讨论。结果与结论GPCR对于AD疾病进程的调节机制,尤其是其与分泌酶形成的复合体对于β-淀粉样蛋白(amyloid-,βAβ)产生以及AD发病的调节机制,具有理想的特异性,可成为抗AD药物的新型潜在靶点。
